Richard C. Mulligan

Richard C. Mulligan
Alma materMassachusetts Institute of Technology, Stanford University
Known forGene Therapy
Scientific career
FieldsGene Therapy
InstitutionsMassachusetts Institute of Technology, Harvard Medical School, Sana Biotechnology
Doctoral advisorPaul Berg
Other academic advisorsAlexander Rich, David Baltimore, Phillip Allen Sharp
Notable studentsJames Wilson (scientist), Constance Cepko, David Sanders (biologist), Roger D. Cone

Richard C. Mulligan (born 1954) is an American scientist who is the Mallinckrodt Professor of Genetics at Harvard Medical School,[1][2][3] the Director of the Harvard Gene Therapy Initiative and a visiting scientist at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology.[4] He is also the head of SanaX at Sana Biotechnology.

  1. ^ "Richard C. Mulligan, Ph.D. | HMS Department of Genetics". genetics.med.harvard.edu. May 2016. Retrieved 2016-06-21.
  2. ^ "Harvard BBS PHD Program".
  3. ^ "Richard C. Mulligan, Ph.D. - DF/HCC". dfhcc.harvard.edu. Archived from the original on 2015-05-31. Retrieved 2016-06-21.
  4. ^ "Richard C. Mulligan". people.forbes.com. Archived from the original on August 4, 2011. Retrieved 2016-06-21.